Literature DB >> 22989831

Rapidly progressive glomerulonephritis associated with PR3-ANCA positive subacute bacterial endocarditis.

Hirotaka Fukasawa1, Maho Hayashi, Naoko Kinoshita, Sayaka Ishigaki, Shinsuke Isobe, Yukitoshi Sakao, Akihiko Kato, Yoshihide Fujigaki, Ryuichi Furuya.   

Abstract

Patients with bacterial endocarditis often have renal complications. This report presents the case of an elderly man with rapidly progressive glomerulonephritis (RPGN) associated with subacute bacterial endocarditis (SBE) due to Enterococcus faecalis infection. The patient was positive for anti-proteinase 3-antineutrophil cytoplasmic antibody (PR3-ANCA) and rheumatoid factor (RF) with hypocomplementemia. Treatment for SBE with antibiotics and the surgical replacement of the affected valves resulted in an improvement of RPGN, the disappearance of PR3-ANCA and RF, and the normalization of hypocomplementemia. This rare case suggests the importance of recognizing the cause of positive PR3-ANCA, because SBE could be an occult cause of RPGN mimicking ANCA-associated vasculitis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22989831     DOI: 10.2169/internalmedicine.51.8081

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  10 in total

1.  Antineutrophil Cytoplasmic Antibody Induction due to Infection: A Patient with Infective Endocarditis and Chronic Hepatitis C.

Authors:  Fareed B Kamar; T Lee-Ann Hawkins
Journal:  Can J Infect Dis Med Microbiol       Date:  2016-03-21       Impact factor: 2.471

Review 2.  Bartonella Endocarditis and Pauci-Immune Glomerulonephritis: A Case Report and Review of the Literature.

Authors:  Jillian E Raybould; Alison L Raybould; Megan K Morales; Misbah Zaheer; Michael S Lipkowitz; Joseph G Timpone; Princy N Kumar
Journal:  Infect Dis Clin Pract (Baltim Md)       Date:  2016-03-01

3.  Bacterial Endocarditis Presenting as Leukocytoclastic Vasculitis.

Authors:  Sarah El Chami; Atieh Jibbe; Shadi Shahouri
Journal:  Cureus       Date:  2017-07-13

4.  Two Cases of Proteinase 3-Anti-Neutrophil Cytoplasmic Antibody (PR3-ANCA)-related Nephritis in Infectious Endocarditis.

Authors:  Kazuya Hirai; Naoto Miura; Masabumi Yoshino; Kanyu Miyamoto; Hironobu Nobata; Takuhito Nagai; Keisuke Suzuki; Shogo Banno; Hirokazu Imai
Journal:  Intern Med       Date:  2016-12-01       Impact factor: 1.271

Review 5.  Diagnostic and treatment challenge of unrecognized subacute bacterial endocarditis associated with ANCA-PR3 positive immunocomplex glomerulonephritis: a case report and literature review.

Authors:  D Bele; N Kojc; M Perše; A Černe Čerček; J Lindič; A Aleš Rigler; Ž Večerić-Haler
Journal:  BMC Nephrol       Date:  2020-01-31       Impact factor: 2.388

Review 6.  Pathogenesis and pathology of anti-neutrophil cytoplasmic antibody(ANCA)-associated vasculitis.

Authors:  Daisuke Tsukui; Yoshitaka Kimura; Hajime Kono
Journal:  J Transl Autoimmun       Date:  2021-03-03

Review 7.  Antineutrophil cytoplasmic antibodies in infective endocarditis: a case report and systematic review of the literature.

Authors:  Inge C Van Gool; Jesper Kers; Jaap A Bakker; Joris I Rotmans; Y K Onno Teng; Martijn P Bauer
Journal:  Clin Rheumatol       Date:  2022-06-23       Impact factor: 3.650

Review 8.  Infective endocarditis with antineutrophil cytoplasmic antibody: report of 13 cases and literature review.

Authors:  Chun-Mei Ying; Dong-Ting Yao; Hui-Hua Ding; Cheng-De Yang
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

Review 9.  Infective endocarditis mimicking ANCA-associated vasculitis: does it require immunosuppressive therapy?: A case report and literature review.

Authors:  Xiao-Dong Shi; Wan-Yu Li; Xue Shao; Li-Mei Qu; Zhen-Yu Jiang
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

10.  Antineutrophil Cytoplasmic Antibodies Associated With Infective Endocarditis.

Authors:  Vincent Langlois; Anais Lesourd; Nicolas Girszyn; Jean-Francois Ménard; Hervé Levesque; Francois Caron; Isabelle Marie
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.